Safety and efficacy of meloxicam 7.5 mg in the treatment of osteoarthritis in Thai patients

Journal of the Medical Association of Thailand

Volumn 84, Issue SUPPL. 2, 2001, Pages

  Bunyaratavej, Narong ^a   Keorochana, Sommart ^b   Pithkul, Sahachart ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Pramongkutkhlao Hospital   (Thailand)

Author keywords

COX2 inhibitor; Meloxicam

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; BLOOD CHEMISTRY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRURITUS; RASH; THAILAND; VISUAL ANALOG SCALE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; THIAZINES; THIAZOLES;

EID: 0035736226     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-5.
2. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclo-oxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990; 86: 1375-9.
3. Vane JR. Towards a better aspirin. Nature 1994; 367: 215-6.
4. Engelhardt G, Bogel R, Schnitzer C, Utzmann R. Meloxicam: Influence on arachinodic acid metaholism. Part II in vivo findings. Biochem Pharmacol 1996; 51: 29-38.
5. Churchill L, Graham AG, Shih CK, et al. Selective inhibition of human cyclo-oxygenase-2 by meloxicam. Inflammopharmacol 1996;4:125-35.
6. Vane JR, Botting RM. the future of NSAID therapy: Selective COX-2 inhibitors. Int J Clin Pract 2000; 54: 7-9.
7. Stichtenoth DO, Wagner B, Frolich JR. Effects of meloxicam and indomethacin on cyclo-oxygenase pathways in healthy volunteers. J Investing Med 1997; 45: 44-9.